HUC-MSC for Treatment of High-risk HPV Infection

StatusUnknown
PhasePhase 1/2
Started

Record status This record was last updated September 24, 2024 (before its estimated September 10, 2025 completion). Its status may not reflect the trial's current state.

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Minor Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
  2. Minor Study First Submitted
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To evaluate the safety and initial effectiveness of human umbilical cord mesenchymal stem cells in HPV clearance.
Trial Details
NCT Number NCT06610773
Lead Sponsor Shanghai East Hospital
Conditions
(from sponsor)
Human Papillomavirus Viruses, Mesenchymal Stem Cells
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov